2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

9- Intestinal Failure

48.20 - The addition of high amylase resistant starch to reduce stool output in patients with short bowel syndrome

Presenter: Kate, Hamilton, Heidelberg, Australia
Authors: Kate Hamilton, Tim Crowe, Brooke Chapman, Peter DeCruz, Adam Testro

The addition of high amylase resistant starch to reduce stool output in patients with short bowel syndrome

Kate Hamilton1, Tim Crowe3, Brooke Chapman1, Peter DeCruz2, Adam Testro1.

1Australian Intestinal Transplant Service, Austin Health, Melbourne, Australia; 2Department of Nutrition and Dietetics, Austin Health, Melbourne, Australia; 3School of Exercise and Nutrition Science, Deakin University, Melbourne, Australia

Introduction: Malabsorptive diarrhoea and dehydration complicating short bowel syndrome (SBS) are difficult to manage despite medical therapy and dietary manipulation. Dietary supplementation with High Amylase Resistant Starch (HARS) has been demonstrated to reduce diarrhoea from a number of causes including gastroenteritis[1][3] and cholera[2]. We hypothesised that the addition of HARS would decrease stool output via the production of short chain fatty acids and a resultant increase in colonic water reabsorption. This pilot study aimed to determine whether the addition of HARS reduced diarrhoea in patients with SBS.

Methods: Participants with SBS with colon in continuity consuming oral diet were recruited from the intestinal rehabilitation clinic at the Austin Hospital, Melbourne. The study involved a 2 week crossover trial. Each participant completed the control (usual diet) followed by the intervention (addition of 50g HARS to usual diet) for 1 week each. Total daily stool weight and number of bowel actions per day were compared between groups using paired t-tests.

Results: Eight adults (58% male, mean age 55.7) were recruited. Five of the 8 participants completed the trial. The length of residual small bowel ranged from 20–120cm. Total daily stool weight was reduced in all participants when consuming HARS (Figure 1). Mean daily stool output was significantly decreased 1049±519g/d to 804±585g/d (p=0.023). The number of bowel actions per day were not significantly different (p=0.6) but were overall numerically reduced in the majority of subjects post-intervention with HARS (Figure 2).

Conclusion: These preliminary data suggest that dietary supplementation of HARS in patients with short bowel syndrome (with colon in continuity) reduces stool output. HARS is a soluble tasteless powder which can be easily and inexpensively incorporated into the diet and may have the potential to decrease reliance on intravenous nutrition or hydration. Further adequately powered trials are required to confirm the effect of HARS on nutrition and hydration status.

This study was funded by a grant received from the Austin Medical Research Foundation.

Austin Health Medical Research Foundation.

[1] Raghupathy P, Ramakrishna B, Oommen S, Ahmed M, Priyaa G, Dziura J, Young G, Binder J. 2006. Amylase-Resistant Starch as adjunct to oral rehydration therapy in children with diarrhea. Journal of pediatric gastroenterology 42:362-368.
[2] Ramakrishna B et al. Amylase resistant starch plus oral rehydration solution for cholera. NEJM 2000; 342:308-13.
[3] Rabbani et al. Green Banana reduces clinical severity of childhood shigellosis. Pediatr Infect Dis J 2009;28: 420-425


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada